Literature DB >> 7028611

Renin-like activity in the rat brain during the development of DOC-salt hypertension.

N Basso, P Ruiz, E Mangiarua, A C Taquini.   

Abstract

Levels and distribution of an angiotensin-forming enzyme, active at the physiological pH (isorenin), were determined in the central nervous system of 24 rats treated with 25 mg/kg of deoxycorticosterone (DOC) subcutaneously, twice a week, plus saline to drink during 30 days and in 14 control animals. Different areas of the brain were excised and homogenized. Renin activity and concentration were determined by incubation of the supernatant of each homogenate at pH 7.2 alone and in the presence of an excess of renin substrate. The angiotensin generated was measured by radioimmunoassay. Concentration of the renin-like enzyme was significantly higher in the posterior hypophysis and in the brain stem of the experimental group; isorenin activity was higher in the hypothalamus, cerebral cortex, cerebellum, and brain stem of the DOC-salt-treated rats than in the control rats. Changes in the angiotensin-forming enzyme in the central nervous system of experimental animals, active at physiological pH, suggest that this isorenin system may play a role in the physiological response to DOC-salt in the rat. The significance of the brain isorenin system in the regulation of blood pressure requires further analysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028611     DOI: 10.1161/01.hyp.3.6_pt_2.ii-14

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Structural insights into central hypertension regulation by human aminopeptidase A.

Authors:  Yang Yang; Chang Liu; Yi-Lun Lin; Fang Li
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

2.  Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide.

Authors:  Stephen F Rodrigues; Daniel Neil Granger
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-05       Impact factor: 6.200

Review 3.  DOCA-Salt Hypertension: an Update.

Authors:  Tyler Basting; Eric Lazartigues
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 4.  Role of angiotensin III in hypertension.

Authors:  Annabelle Reaux-Le Goazigo; Xavier Iturrioz; Celine Fassot; Cedric Claperon; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

5.  Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.

Authors:  Marie-Claude Fournie-Zaluski; Celine Fassot; Bruno Valentin; Dragan Djordjijevic; Annabelle Reaux-Le Goazigo; Pierre Corvol; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 6.  Aminopeptidase A inhibitors as centrally acting antihypertensive agents.

Authors:  Laurence Bodineau; Alain Frugière; Yannick Marc; Cédric Claperon; Catherine Llorens-Cortes
Journal:  Heart Fail Rev       Date:  2008-01-03       Impact factor: 4.214

7.  Rapid metabolism of exogenous angiotensin II by catecholaminergic neuronal cells in culture media.

Authors:  Urmi Basu; Javier Seravalli; Nandakumar Madayiputhiya; Jiri Adamec; Adam J Case; Matthew C Zimmerman
Journal:  Physiol Rep       Date:  2015-02-03

Review 8.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.